Relationship between HN1 and hepatocellular carcinoma: a medical records based study

Relationship between expression of HN1 and clinicopathological factors in hepatocellular carcinoma tissues and cell lines

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029173

Enrollment

Unknown

Registered

2020-01-17

Start date

2020-01-20

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

43 Years to 76 Years

Inclusion criteria

Inclusion criteria: patients didn't receive chemotherapy or radiation before surgery,Postoperative pathology confirmed hepatocellular carcinoma

Exclusion criteria

Exclusion criteria: patients have received chemotherapy or radiation before surgery,Or postoperative pathology confirmed no hepatocellular carcinoma

Design outcomes

Primary

Measure	Time frame
hematological and neurological expressed 1;	—

Countries

China

Contacts

Public ContactYamin Zhang

Tianjin Medical University General Hospital

13802122219@163.com+86 13802122219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026